- Home
- ATOS vs PROV Comparison
ATOS vs PROV Comparison
Compare ATOS & PROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- PROV
- Stock Information
- Founded
- ATOS 2009
- PROV 1956
- Country
- ATOS United States
- PROV United States
- Employees
- ATOS N/A
- PROV N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- PROV Savings Institutions
- Sector
- ATOS Health Care
- PROV Finance
- Exchange
- ATOS Nasdaq
- PROV Nasdaq
- Market Cap
- ATOS 112.5M
- PROV 100.7M
- IPO Year
- ATOS 2012
- PROV 1996
- Fundamental
- Price
- ATOS $0.85
- PROV $15.61
- Analyst Decision
- ATOS Strong Buy
- PROV Hold
- Analyst Count
- ATOS 3
- PROV 1
- Target Price
- ATOS $6.17
- PROV $16.00
- AVG Volume (30 Days)
- ATOS 1.5M
- PROV 6.5K
- Earning Date
- ATOS 08-11-2025
- PROV 07-28-2025
- Dividend Yield
- ATOS N/A
- PROV 3.58%
- EPS Growth
- ATOS N/A
- PROV N/A
- EPS
- ATOS N/A
- PROV 0.97
- Revenue
- ATOS N/A
- PROV $39,909,000.00
- Revenue This Year
- ATOS N/A
- PROV $3.06
- Revenue Next Year
- ATOS N/A
- PROV $9.15
- P/E Ratio
- ATOS N/A
- PROV $16.08
- Revenue Growth
- ATOS N/A
- PROV 1.24
- 52 Week Low
- ATOS $0.55
- PROV $12.01
- 52 Week High
- ATOS $1.66
- PROV $16.70
- Technical
- Relative Strength Index (RSI)
- ATOS 51.17
- PROV 53.89
- Support Level
- ATOS $0.81
- PROV $15.39
- Resistance Level
- ATOS $0.92
- PROV $15.90
- Average True Range (ATR)
- ATOS 0.05
- PROV 0.37
- MACD
- ATOS -0.00
- PROV 0.00
- Stochastic Oscillator
- ATOS 52.73
- PROV 66.30
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.